Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diabetes and Cardiovascular Disease
1999 Standout
National High Blood Pressure Education Program Working Group report on hypertension in diabetes.
1994
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up
1991
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
1992
Thiazolidinediones
2004 Standout
HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women
1997
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Hyperinsulinemia Induces Myocardial Infarctions and Arteriolar Medial Hypertrophy in Spontaneously Hypertensive Rats
1997
Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians
2008
Metabolic syndrome and target organ damage in untreated essential hypertensives
2004
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Acute myocardial infarction in the diabetic patient: Pathophysiology, clinical course and prognosis
1992
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
Serum Uric Acid and Cardiovascular Mortality
2000 Standout
The metabolic syndrome: is this diagnosis necessary?1,2
2006
The metabolic syndrome
2010 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Relationship between Generalized and Upper Body Obesity to Insulin Resistance in Asian Indian Men1
1999
Serum Uric Acid and Risk of Coronary Heart Disease
2000
Uric Acid and Cardiovascular Risk
2008 Standout
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
1991
Serum Insulin and Other Cardiovascular Risk Indicators in Children, Adolescents and Young Adults
1991
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein E phenotype A report from the multiple risk factor intervention trial
1994
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects
1999
Serum Insulin and Incident Coronary Heart Disease in Middle-aged British Men
1996
Plasma Uric Acid Level and Risk for Incident Hypertension Among Men
2006
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
The metabolic syndrome
2005 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
The metabolic syndrome and cardiovascular disease
2006
Polycystic Ovary Syndrome
1995 Standout
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Diabetes and Atherosclerosis
2002 Standout
The metabolic syndrome: prevalence in worldwide populations
2004
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia
1993
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Syndrome X: A syndrome of insulin resistance. Epidemiological and clinical evidence
1994
Predicting Obesity in Young Adulthood from Childhood and Parental Obesity
1997 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Induction of insulin resistance by androgens and estrogens.
1994
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
The metabolic syndrome—a new worldwide definition
2005 Standout
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease
1996
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
1990
Prediabetes: a high-risk state for diabetes development
2012 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations
1992
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Risk stratification in hypertension: new insights from the Framingham study*1
2000
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Relationships of generalized and regional adiposity to insulin sensitivity in men.
1995
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.
1993
The Effects of Metformin on Body Mass Index and Glucose Tolerance in Obese Adolescents With Fasting Hyperinsulinemia and a Family History of Type 2 Diabetes
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Diabetes mellitus and hypertension.
1992
Uric acid metabolism and tubular sodium handling. Results from a population-based study.
1993
Definition of Metabolic Syndrome
2004 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance
1999
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Concordance for Dyslipidemic Hypertension in Male Twins
1991
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
1999
Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus
1998
Blood Lipid Measurements
1992
Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
1998
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Allelochemics: Chemical Interactions between Species
1971 StandoutScience
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Fasting Serum Insulin Levels and Coronary Heart Disease in a Danish Cohort: 17-year Follow-up
1995
Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
2009
Asymptomatic atherosclerosis and insulin resistance.
1991
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis
2000
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
1997
Genetic Dissection of Complex Traits
1994 StandoutScience
Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk
2007
Distribution and Correlates of Insulin in Elderly Men
1995
The Relation between Insulin Sensitivity and the Fatty-Acid Composition of Skeletal-Muscle Phospholipids
1993
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
2005
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol
2003
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Catnip: Its Raison d'Être
1964 Science
Persistent Elevation of Plasma Insulin Levels Is Associated With Increased Cardiovascular Risk in Children and Young Adults
1996
Works of L Luchetti being referenced
High Plasma Insulin and Triglyceride Concentrations and Blood Pressure in Offspring of People with Impaired Glucose Tolerance
1990
Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance
1989
[Effect of the somatotropic hormone and dietary regimen on amino nitrogen in the blood].
1960